ONWARD

Developer of an implantable neurostimulation system (INS) that provides real-time motion feedback and utilizes training tools to rehabilitate patients with neurological disorders, such as spinal cord injuries (SCI)

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Biomedical engineering

Neurotechnology

Neurostimulation

...

Location

Newfoundland and Labrador

B2X

0

CEO

Founder

Vincent Delattre

Gregoire Courtine

Legal Name

ONWARD Medical BV

Number of Employees (Ranges)

51 – 2000

Email Address

info@gtxmedical.com

Phone Number

+31402882830

Full Address

High Tech Campus, Building 32, Eindhoven, North Brabant 5656, NL0

Investors

Netherlands Enterprise Agency

Wellington Partners

European Innovation Council

Founded Date

2014

0

Total Funding Amount (USD)

58,000,000

Latest Funding Round Date

October 24, 2025

Stock Symbol

EBR:ONWD

Former CEO

Also Known As

GTX medical

G-Therapeutics

Latest Funding Type

Initial public offering (IPO)

Patents Assigned (Count)

1

Country

Headquarters

Other attributes

Company Operating Status

Active

Creative Work IMDb ID

Latest Funding Round Amount (USD)

58,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like ONWARD

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.